advanced search

GI/ORAL

SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE
EXPERT VIEW
Rina Chokshi
SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE
Rina Chokshi discusses the benefits of naturally derived, sustainable ingredients and their benefits to the environment and pharmaceutical industry.
LEADING PHARMACEUTICAL DEVELOPMENT IN A SUSTAINABLE WAY – SKYEPHARMA’S EXAMPLE
SUSTAINABILITY
Dr Aline Moulin
Skyepharma Production
LEADING PHARMACEUTICAL DEVELOPMENT IN A SUSTAINABLE WAY – SKYEPHARMA’S EXAMPLE
Aline Moulin and Laurent Rigaudeau discuss how Skyepharma fulfils its sustainable development policy through its technologies and processes.
NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT
SUSTAINABILITY
Andrea Cusack
leon-nanodrugs
NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT
Andrea Cusack discusses how, by using bottom-up nanotechnology techniques, efficiencies can be found both in the development of new chemical entities and in the repurposing of existing drugs, and how these efficiencies translate into reduced energy requirements and therefore more sustainable industry practices.
ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM
ROUNDTABLE
Dr Jeremy Drummond
ROUNDTABLE: JEREMY DRUMMOND, MEDPHARM; STEPHEN RODE, LONZA; AND TORKEL GREN, RECIPHARM
In this roundtable discussion, Jeremy Drummond, Stephen Rode and Torkel Gren discuss trends with different drug dosage forms for different routes of administration, the rise of patient centricity including the shift from the blockbuster model to more tailored products.
TFF AND UNION AGREE LICENSING PACT FOR TFF TECHNOLOGY WITH NICLOSAMIDE FOR THE TREATMENT OF COVID-19
TFF AND UNION AGREE LICENSING PACT FOR TFF TECHNOLOGY WITH NICLOSAMIDE FOR THE TREATMENT OF COVID-19
UNION therapeutics has acquired an option to a worldwide, exclusive licence to TFF Pharmaceuticals' Thin Film Freezing (TFF) technology, in combination with niclosamide, covering oral and inhalation formulations, potentially for covid-19, as well as other niclosamide-based therapies.
MAKING MEDICINE EASIER TO TAKE
GI/ORAL
Graeme Macleod
MAKING MEDICINE EASIER TO TAKE
Graeme Macleod and Wayne Camarco discuss the rational design of excipients to meet the needs of patient-centric formulations.
FORMULATION FLEXIBILITY WITH NEW ERA HPMC CAPSULES
GI/ORAL
Sanjay Powale
ACG
FORMULATION FLEXIBILITY WITH NEW ERA HPMC CAPSULES
Sanjay Powale, Anita Solanki and Dorene Almeida discuss the benefits of HPMC capsules in overcoming challenges faced by traditional gelatin capsules.
THE FLOWABILITY OF LACTOSE POWDERS TO OPTIMISE TABLETING PROCESSES
GI/ORAL
Dr Aurelien Neveu
Granutools
THE FLOWABILITY OF LACTOSE POWDERS TO OPTIMISE TABLETING PROCESSES
Aurélien Neveu, Pauline Janssen and Geoffroy Lumay discuss how new measurement methods can help gain a better understanding of the flowability of lactose powders – a necessary step for future improvement of oral delivery systems.
NANOPARTICLE ENGINEERING: REVOLUTIONISING ORAL DRUG DEVELOPMENT & DELIVERY
GI/ORAL
Dr Satu Lakio
Nanoform
NANOPARTICLE ENGINEERING: REVOLUTIONISING ORAL DRUG DEVELOPMENT & DELIVERY
Satu Lakio and Niklas Sandler discuss the benefits of nanoparticle engineering technology as a means of improving the bioavailability and solubility of drug compounds.
TECHNOLOGY SHOWCASE: Röchling Medical’s Sympfiny<sup>®</sup>
GI/ORAL
Tamas Öri
Röchling Medical
TECHNOLOGY SHOWCASE: Röchling Medical’s Sympfiny®
Röchling Medical presents Sympfiny®, an innovative system for dosing and delivering multiparticulate, dry powder, and microsphere drug formulations for oral delivery, which it developed In collaboration with HS Design.
AN EASY PILL TO SWALLOW
GI/ORAL
Kelly Boyer
Colorcon
AN EASY PILL TO SWALLOW
Kelly Boyer and Ali Rajabi-Siahboomi explore the role of different tablet coating materials in improving the patient experience and adherence to prescription regimens.
INTERVIEW WITH MARIA FLYNN, ADARE PHARMACEUTICALS
INTERVIEW
Maria Flynn
Adare Pharma Solutions
INTERVIEW WITH MARIA FLYNN, ADARE PHARMACEUTICALS
Adare Pharma's Maria Flynn talks with ONdrugDelivery about trends in the oral drug development and delivery space, completing the Orbis Biosciences acquisition during a global pandemic, and how the excellent technology portfolio and strategic fit between Orbis and Adare form part of the combined organisation’s unique story.
INNOVATIONS IN 3D PRINTED PHARMACEUTICALS
GI/ORAL
Sarah Trenfield
FabRx
INNOVATIONS IN 3D PRINTED PHARMACEUTICALS
Sarah Trenfield, Abdul Basit and Alvaro Goyanes discuss the latest innovations in 3D printed pharmaceuticals.
RECENT DEVELOPMENT IN COMPLEX TABLET FORMULATION DESIGN FOR VERSATILE APPLICATIONS
GI/ORAL
Dr Mathieu Degomme
Skyepharma Production
RECENT DEVELOPMENT IN COMPLEX TABLET FORMULATION DESIGN FOR VERSATILE APPLICATIONS
Mathieu Degomme and Aline Moulin outline three case studies from recent early-stage development programmes to illustrate what kind of complex tablets can be developed to meet specific target dissolution profiles for versatile applications.
THE RISE OF COMPLEX ORAL DELIVERY SYSTEMS
EXPERT VIEW
María FM Balson
THE RISE OF COMPLEX ORAL DELIVERY SYSTEMS
María Fernández-Martos Balson and Bastiaan De Leeuw explore the oral delivery of biologics and the challenges that must be overcome in order to enhance bioavailability. The authors also take a look at some recently developed drug-device combinations.
OPTICORE™: A FIRST-IN-CLASS COLONIC TARGETING TECHNOLOGY
GI/ORAL
Dr Felipe Varum
OPTICORE™: A FIRST-IN-CLASS COLONIC TARGETING TECHNOLOGY
Felipe Varum, Roberto Bravo and Abdul Basit discuss the use of colonic targeting coating technology OPTICORE™ to deliver APIs in the treatment of ulcerative colitis (UC) patients.
INTERVIEW WITH MILENA BATALLA, PHD, PANARUM
INTERVIEW
Milena Batalla
INTERVIEW WITH MILENA BATALLA, PHD, PANARUM
Dr Batalla introduces the company and describes its Proteoral® technology for the oral delivery of proteins to the bloodstream, therapeutic applications, and products to date. Panarum is an Argentine company and this interview is presented here in Spanish and English, an exciting first for ONdrugDelivery!
UNIQUE MINITABLET DISPENSER MEETS FLEXIBLE ORAL DOSING NEED
GI/ORAL
Bjørn Knud Andersen
Phillips Medisize
UNIQUE MINITABLET DISPENSER MEETS FLEXIBLE ORAL DOSING NEED
Bjørn Knud Andersen discusses how an innovative minitablet dispenser that mounts on a standard medication container simply and effectively meets the growing needs of patients in paediatrics, geriatrics, oncology and other areas who require reliable customised oral dosing.
POLYMER CHEMISTRY’S INFLUENCE ON CR TABLETS MANUFACTURED VIA DIRECT COMPRESSION
GI/ORAL
Dr Nasrin Mahmoudi
IFF Pharma Solutions
POLYMER CHEMISTRY’S INFLUENCE ON CR TABLETS MANUFACTURED VIA DIRECT COMPRESSION
Nasrin Mahmoudi, Kevin McIntyre, Joseph Lee, Holly Bertrand, Yeli Zhang, Fernanda Onofre and Amina Faham investigate the effect of a simple direct compression method on controlled-release matrix tablet formulations.
Stabilitech Recognised by WHO, seeks £6m funding to make oral SARS-COV-2 vaccine available by end of 2020
Stabilitech Recognised by WHO, seeks £6m funding to make oral SARS-COV-2 vaccine available by end of 2020
Stabilitech Biopharma, which is developing OraPro-COVID-19, an oral coronavirus vaccine, has been formally recognised on the international stage by the WHO as a vaccine developer, and seeks £6 million to fund clinical trials and manufacturing required to make the vaccine available by the end of 2020.
Lexaria Bioscience Expands Pharma Division for development of Lipophilic Antivirals against COVID-19
Lexaria Bioscience Expands Pharma Division for development of Lipophilic Antivirals against COVID-19
Lexaria is to investigate how its patented DehydraTECH drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19.  Lexaria intends to expand collaboration with leading laboratories as soon as possible.
THE TRUSTED TABLET: A NEW LEVEL OF SUPPLY CHAIN SECURITY FROM MASS DIGITALISATION OF MEDICINES
CONNECTIVITY
Kelly Boyer
Colorcon
THE TRUSTED TABLET: A NEW LEVEL OF SUPPLY CHAIN SECURITY FROM MASS DIGITALISATION OF MEDICINES
Kelly Boyer, Trent Lund and Barry McDough describe a means of mass digitalising medicines to address the problem of illegal and unauthorised production of pharmaceutical products in a meaningful way.
TRANSFORMING HEALTHCARE – HOW CURATIVE THERAPIES WILL DISRUPT THE MARKET
EXPERT VIEW
Dr Ulrica Sehlstedt
TRANSFORMING HEALTHCARE – HOW CURATIVE THERAPIES WILL DISRUPT THE MARKET
Ulrica Sehlstedt, Craig Wylie, Thomas Unger, Rebecka Axelsson Wadman, Vikas Kharbanda, and Satoshi Ohara, all members of Arthur D. Little’s Healthcare and Life Sciences Practice, explain how the shift to curative treatments promises to transform the entire healthcare ecosystem. 
HOW TO GAIN A FULL UNDERSTANDING OF POWDER FLOW PROPERTIES, AND THE BENEFITS OF DOING SO
RESPIRATORY
Dr Geoffroy Lumay
Granutools
HOW TO GAIN A FULL UNDERSTANDING OF POWDER FLOW PROPERTIES, AND THE BENEFITS OF DOING SO
Geoffroy Lumay, Naveen Mani Tripathi and Filip Francqui show how the association of three recently developed flow measurement techniques can be used to gain valuable insights into powder properties and characteristics.
Top